Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patients After Hematopoietic Stem Cell Transplantation”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00326157
What this trial is testing

PROPHESSOR: AmBisome in Antifungal Primary Prophylaxis Treatment of High Risk Patients Undergoing Allogeneic Stem Cell Transplantation

Who this might be right for
Fungus Diseases
Gilead Sciences 34
Not applicableUnknownNCT05200338
What this trial is testing

Preservation and Transfer of HBV Immunity After Allogeneic HSCT for SCD

Who this might be right for
Sickle Cell Disease
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 30
Testing effectiveness (Phase 2)Study completedNCT01063647
What this trial is testing

Dose-range Finding Treosulfan-based Conditioning

Who this might be right for
Hematological Malignancies
medac GmbH 56
Large-scale testing (Phase 3)UnknownNCT00884338
What this trial is testing

Cognitive Function After Stem Cell Transplantation

Who this might be right for
FatigueCognitive ImpairmentStem Cell Transplantation
Charite University, Berlin, Germany 60
Testing effectiveness (Phase 2)Study completedNCT01525407
What this trial is testing

Donor Atorvastatin Treatment for Preventing Severe Acute Graft-Versus-Host Disease in Patients Undergoing Myeloablative Peripheral Blood Stem Cell Transplantation

Who this might be right for
Malignant Neoplasm
Fred Hutchinson Cancer Center 83
Very early researchUnknownNCT02853942
What this trial is testing

Autologous Adipose Mesenchymal Stem Cell Transplantation in the Treatment of Patients With Hemifacial Spasm

Who this might be right for
Injury of Facial Nerve, Unspecified Side, Initial Encounter
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 100
Testing effectiveness (Phase 2)UnknownNCT05599256
What this trial is testing

Prevention of Severe Acute Graft-versus-host Disease in Pediatric Patients Using a daGOAT Model

Who this might be right for
Transplant-Related Disorder
Institute of Hematology & Blood Diseases Hospital, China 40
Not applicableLooking for participantsNCT06125483
What this trial is testing

TBI/Flu/Bu/Mel Combined With Secondary UCBT in Patients With Hematological Malignancies Who Relapsed After Allo-HSCT

Who this might be right for
Hematopoietic MalignancyRelapse/RecurrenceHematopoietic Stem Cell Transplantation
The First Affiliated Hospital of Soochow University 38
Testing effectiveness (Phase 2)Study completedNCT00005854
What this trial is testing

Bone Marrow Transplantation in Treating Patients With Hematologic Cancer

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more
Fred Hutchinson Cancer Center
Very early researchUnknownNCT05528354
What this trial is testing

Venetoclax and Decitabin Based Conditioning Regimen Followed With Post-HSCT Decitabin Maintenance Therapy in TP53 Mutant AML/MDS Patients

Who this might be right for
Hematopoietic Stem Cell TransplantationTP53
Zhejiang University 58
Not applicableLooking for participantsNCT07688759
What this trial is testing

CMV-CMI in csCMVi After HSCT

Who this might be right for
Cytomegalovirus InfectionsHematopoietic Stem Cell Transplantation (HSCT)Immune Reconstitution
The First Affiliated Hospital of Soochow University 40
Testing effectiveness (Phase 2)Study completedNCT00489203
What this trial is testing

Beclomethasone Dipropionate in Preventing Acute Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer

Who this might be right for
Hematopoietic/Lymphoid CancerAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in Remission+133 more
Fred Hutchinson Cancer Center 140
Testing effectiveness (Phase 2)Study completedNCT00003148
What this trial is testing

Interleukin-2 in Treating Patients With Relapsed or Refractory Acute Myelogenous Leukemia

Who this might be right for
Leukemia
European Organisation for Research and Treatment of Cancer - EORTC 86
Testing effectiveness (Phase 2)Study completedNCT00046852
What this trial is testing

Chemotherapy and Peripheral Stem Cell Transplantation Followed By Immunotherapy in Treating Patients With Multiple Myeloma

Who this might be right for
InfectionMultiple Myeloma and Plasma Cell Neoplasm
University of Maryland, Baltimore
Large-scale testing (Phase 3)Ended earlyNCT00117702
What this trial is testing

Prevention of the Graft-Versus-Host-Disease in Patients After Stem Cell Transplantation With Tacrolimus and Everolimus

Who this might be right for
Graft vs Host Disease
Technische Universität Dresden 24
Testing effectiveness (Phase 2)Study completedNCT02806375
What this trial is testing

PTCy and Ruxolitinib GVHD Prophylaxis in Myelofibrosis

Who this might be right for
Primary MyelofibrosisMyeloproliferative Disorders
St. Petersburg State Pavlov Medical University 20
Testing effectiveness (Phase 2)Study completedNCT01386619
What this trial is testing

NK DLI in Patients After Human Leukocyte Antigen (HLA)-Haploidentical Hematopoietic Stem Cell Transplantation (HSCT)

Who this might be right for
Leukemia, Myeloid, AcutePrecursor Cell Lymphoblastic Leukemia-LymphomaMyelodysplastic Syndromes+3 more
University Hospital, Basel, Switzerland 15
Not applicableEnded earlyNCT02360111
What this trial is testing

GVHD Prophylaxis With Post Transplant Cyclophosphamide for Patients With Renal Insufficiency Undergoing a Conventional 8/8 HLA-matched Related or Unrelated Donor Allogeneic Hematopoietic Stem Cell Transplant

Who this might be right for
LeukemiaMyelodysplastic SyndromeNon-Hodgkin's Lymphoma
Memorial Sloan Kettering Cancer Center 3
Large-scale testing (Phase 3)Ended earlyNCT04326764
What this trial is testing

Panobinostat Maintenance After HSCT fo High-risk AML and MDS

Who this might be right for
Acute Myeloid Leukaemia (AML)Myelodysplastic Syndromes (MDS)
Goethe University 52
Testing effectiveness (Phase 2)Ended earlyNCT01116232
What this trial is testing

Sirolimus, Tacrolimus, Thymoglobulin and Rituximab as Graft-versus-Host-Disease Prophylaxis in Patients Undergoing Haploidentical and HLA Partially Matched Donor Hematopoietic Cell Transplantation

Who this might be right for
Chronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+5 more
Barbara Ann Karmanos Cancer Institute 4
Next Page